| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/27/2004 | US20040101855 Modulation of PPAR binding protein expression |
| 05/27/2004 | US20040101854 Modulation of BCL2-associated athanogene expression |
| 05/27/2004 | US20040101853 Modulation of STAT2 expression |
| 05/27/2004 | US20040101835 Using circularized probe to detect, amplify and sequence target nucleotide sequences; restriction fragment length polymorphisms |
| 05/27/2004 | US20040101820 Polynucleotide probe and primer originating in hepatitis e virus of japanese, chips having the same, kits having the same and method of detecting hepatits e virus using the same |
| 05/27/2004 | CA2769657A1 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
| 05/27/2004 | CA2505931A1 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | CA2505895A1 Expression profiling based on histocultures |
| 05/27/2004 | CA2505807A1 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | CA2505698A1 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
| 05/27/2004 | CA2505330A1 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | CA2505090A1 Conjugated oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504929A1 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504818A1 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | CA2504720A1 Chimeric oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504701A1 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504554A1 2'-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | CA2503621A1 Methods and compositions for diagnosing dysplasia |
| 05/26/2004 | EP1422233A1 Chemical copying of connectivity information in branched DNA structures |
| 05/26/2004 | EP1421224A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 05/26/2004 | EP1421213A2 Labeled nucleoside polyphosphates |
| 05/26/2004 | EP1421201A2 Methods for immobilizing molecules to a solid phase and uses thereof |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421095A1 Assay for detection of human parvovirus b19 nucleic acid |
| 05/26/2004 | EP1420879A2 Treatment of substrates using an electrochemical method |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1084134A4 Activators for oligonucleotide synthesis |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | CN1500094A Building blocks for solution phase synthesis of oligonucleotides |
| 05/26/2004 | CN1498902A Immune suppression fusion protein, its coded nucleic acid and application |
| 05/26/2004 | CN1498897A Gene PSME3 of fat thickness at back of pig as well as preparation method |
| 05/26/2004 | CN1498896A Heavy PSME1 gene for pig to pass breast, and its prepn. method |
| 05/26/2004 | CN1498895A Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus |
| 05/26/2004 | CN1498894A Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody |
| 05/26/2004 | CN1498893A Paddy rice gene Xa4 of anti bacterial leaf spot |
| 05/26/2004 | CN1151374C Self-addressable self-assembling microelectronic system and devices for molecular biological analysis and diagnostics |
| 05/26/2004 | CN1151267C Method for producing human brain-derived neurotrophic factor NDNF by using methanol yeast (pichia pastoris) and its application |
| 05/26/2004 | CN1151260C Gametophyte pollen self-incompatibity gene and its application |
| 05/26/2004 | CN1151251C New human-phosphoguanosine reductase, its coding sequence and application |
| 05/26/2004 | CN1151168C Antisense thio-oligonucleic acid of target protein kinase C-alpha and its medicine composition and application in treating cancer |
| 05/26/2004 | CN1151166C Crystal of diruidine tetraphosphate or salt thereof and method for preparing same, and method for producing said compound |
| 05/26/2004 | CA2448098A1 Ultrasensitive detection of pathogenic microbes |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740520 Cytokine receptor and nucleic acids encoding the same |
| 05/25/2004 | US6740506 End selection in directed evolution |
| 05/25/2004 | US6740491 Detecting genetically engineered nucleotide sequences; obtain nucleotide sequeces, incubate with nanoparticle, join, monitor adjustment in nucleotide sequence activity |
| 05/25/2004 | CA2261576C Probes for detecting and identifying helicobacter pylori |
| 05/25/2004 | CA2176745C Nucleic acid analogs with a chelating functionality |
| 05/22/2004 | CA2448515A1 Compositions and methods for identifying thymidylate synthase modulators |
| 05/21/2004 | WO2004042363A2 In vivo imaging of e2f-regulated bioluminescent proteins |
| 05/21/2004 | WO2004042346A2 Methods and compositions for diagnosing and monitoring transplant rejection |
| 05/21/2004 | WO2004042344A2 Fabrication of a high resolution biological molecule detection device with gold electrical conductors |
| 05/21/2004 | WO2004042086A1 Gas jet process and apparatus for high-speed amplification of dna |
| 05/21/2004 | WO2004042037A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/21/2004 | WO2004042029A2 Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use |
| 05/21/2004 | WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | WO2004041924A2 Non-phosphorous-linked oligomeric compounds and their use in gene modulation |
| 05/21/2004 | WO2004041889A2 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/21/2004 | WO2004041843A2 Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 05/21/2004 | WO2004041205A2 Ha4, a new osteoblast- and chondrocyte-specific small secreted peptide, compositions and methods of use |
| 05/21/2004 | WO2004041196A2 Methods and compositions for the diagnosis of neuroendocrine lung cancer |
| 05/21/2004 | WO2004041194A2 Inhibition of hiv-1 replication |
| 05/21/2004 | WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5 |
| 05/21/2004 | WO2004041076A2 Methods of detecting colorectal cancer |
| 05/21/2004 | WO2004031351A9 Microarrays having multiple oligonucleotides in single array features |
| 05/21/2004 | WO2004024087A9 Methods of diagnosing and treating hyperproliferative disorders |
| 05/21/2004 | WO2004020675A9 Polymorphism detection among homologous sequences |
| 05/21/2004 | WO2004009541A3 Antisense modulation of endothelial lipase expression |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003085110A3 Oligomeric compounds for the modulation hif-1alpha expression |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003066650A3 Short interfering rna molecules directed towards a tissue factor coding nucleic acid |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2002096923B1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 05/21/2004 | WO2002081490A8 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 05/21/2004 | CA2504762A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/21/2004 | CA2504694A1 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/21/2004 | CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 05/21/2004 | CA2483481A1 Method for diagnosing and monitoring cardiac transplant rejection |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040097722 Preparation of phosphorothioate oligomers |
| 05/20/2004 | US20040097711 Chimeric monoclonal antibody for diagnosis, prevention and treatment of immunological, nervous system, developmental, muscle and cell proliferative disorders |
| 05/20/2004 | US20040096978 Crown ether chelators, including fluorescent derivatives chelate metal cations; detection, discrimination and quantification of metal cations |
| 05/20/2004 | US20040096960 Microchannel apparatus for use in nucleic acid sequencing, enzyme kinetics and diagnostics screening |
| 05/20/2004 | US20040096947 Biosynthesis using enzyme; immobilized to activated polymer support |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096889 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096886 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |
| 05/20/2004 | US20040096885 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |
| 05/20/2004 | US20040096878 For anticancer/tumor agents; in vivo gene expression profiling; solid phase synthesis |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096870 Methods of detecting sequence differences |
| 05/20/2004 | US20040096848 Oligomeric compounds for the modulation HIF-1alpha expression |
| 05/20/2004 | US20040096838 DNA chip and its preparation |
| 05/20/2004 | US20040096837 Non-contiguous oligonucleotide probe arrays |
| 05/20/2004 | US20040096835 Modulation of TNFSF14 expression |
| 05/20/2004 | US20040096834 Modulation of HIP-1 protein interactor expression |